Key Stocks to Watch This Friday: ATEME, Cellectis, and 3 Other Annual Results
This Friday, six listed companies are on the agenda with their annual results. Here's an overview of the stocks to watch before the market opens.
Review of Key Company Performances
ATEME revealed its annual results for 2025 yesterday, which were well received by investors: the stock rose by 6.13% in the last session, to 7.96 euros, one of the best performances on the stock exchange among the publications of the day. Specializing in video compression solutions, the company has undergone a transition phase towards software and cloud in recent years. Cellectis, on the other hand, presented its annual accounts last night in a still challenging context for biotechs: the stock fell by 3.57%, to 2.97 euros. As a pioneer in genome editing gene therapies, the company remains highly cash-intensive, which explains the particular attention of the markets with each publication. A striking contrast at Courtois, a discreet regional banking institution whose 2025 annual results were published yesterday: the stock dropped 5%, to 114 euros, a reaction that contrasts with the usual stability of this less liquid stock. As for Nyxoah, a Belgian medtech specializing in the treatment of sleep apnea, its annual results revealed yesterday left the price almost stable, at 2.655 euros (-1.12%), indicating a publication generally in line with expectations.
Upcoming Announcements and Expectations
Today, Soditech publishes its annual results, following a positive session for the stock, which was up 2.84% at 7.25 euros. As a player in the aerospace and defense engineering sector, the company benefits from an expanding industry, which enhances interest in its annual accounts. Finally, Wallix presented its 2025 results yesterday: the cybersecurity software publisher, specializing in privileged access management, saw its stock fall by 4.78% to 20.90 euros, reflecting the high expectations the market holds for French technology stocks at each fiscal year-end.
